SCHEMBL3853440

SCHEMBL3853440

O=C(O)c1cccc(N2CCN(c3ncnc4ccc(-c5cnn(C(c6ccccc6)(c6ccccc6)C6C=CC=CC6)c5)cc34)CC2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.37
HPGD P15428 2/20 0.37
CLK4 Q9HAZ1 6/20 0.36
HIF1A Q16665 3/20 0.36
ALDH1A1 P00352 4/20 0.36
CYP1A2 P05177 4/20 0.36
HSD17B10 Q99714 3/20 0.36
CYP2C9 P11712 1/20 0.36
EGLN1 Q9GZT9 8/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
AKT1 P31749 1/20 0.35
LMNA P02545 4/20 0.34
CYP2D6 P10635 4/20 0.34
MAPK1 P28482 3/20 0.34
TSHR P16473 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4716053 0.93 CNR1 (0.38) CYP3A4HPGDCLK4HIF1AALDH1A1
SCHEMBL3846738 0.91 ACHE (0.39) CYP3A4HPGDCLK4HIF1AALDH1A1
SCHEMBL3847124 0.89 MAPT (0.42) CYP3A4HPGDCLK4HIF1AALDH1A1
SCHEMBL3845846 0.89 PHGDH (0.41) CYP3A4HPGDCLK4HIF1AALDH1A1
SCHEMBL3853439 0.85 CLK4 (0.42) CYP3A4HPGDCLK4HIF1AALDH1A1
SCHEMBL3846797 0.84 CYP3A4 (0.49) CYP3A4HPGDCLK4HIF1AALDH1A1
SCHEMBL3846271 0.83 CYP3A4 (0.40) CYP3A4HPGDCLK4HIF1AALDH1A1
SCHEMBL3847516 0.82 CYP3A4 (0.36) CYP3A4HPGDCLK4HIF1AALDH1A1
SCHEMBL3845654 0.79 ACHE (0.38) CYP3A4CLK4HIF1AALDH1A1CYP1A2
SCHEMBL3852228 0.79 CYP3A4 (0.36) CYP3A4HPGDCLK4HIF1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed